Search Results 501-510 of 18362 for total bilirubin

1. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   Total bilirubin ≤ 1.5 x ULN OR direct bilirubin ≤ ULN for patients with total bilirubin levels > 1.5 x ULN (performed within 14 days prior to registration).

2. PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) - Mayo Clinic

   Hemoglobin > 10 g/dL • Total bilirubin ≤ 1.5 × ULN; Platelet count ≥ 100 × 109/L • Serum creatinine ≤ 1.5 × ULN. Willingness and ability to complete the ...

3. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

   Obtained =< 14 days prior to registration: Total bilirubin =< 1.5 x upper limit of normal (ULN) or direct bilirubin =< ULN; Obtained =< 14 days prior to ...

4. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Total bilirubin ≤ ULN; Alanine aminotransferase (ALT/SGPT) and aspartate ... NOTE: If a urine test is positive or cannot be confirmed as negative, a serum ...

5. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

   Total bilirubin > 1.5x ULN;; AST/SGOT and ALT/SGPT > 2.5x ULN (AST and ALT > 5x ULN in the presence of liver metastases);; Serum creatinine > 1.5x ULN and a ...

6. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have moderate or advanced liver fibrosis - Mayo Clinic

   OR total serum bilirubin concentration ≥1.5x ULN (participants with a documented history of Gilbert's syndrome can be enrolled if the direct bilirubin is ...

7. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or direct bilirubin ≤ ULN if total bilirubin is > 1.5 x ULN (obtained ≤ 15 days prior to registration).

8. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

   Serum total bilirubin ≤ 2.0 mg/dL (34 μmol/L) except in cases of Gilbert's syndrome, then ≤ 5.0 mg/dL (86 μmol/L);; Subjects receiving polatuzumab vedotin ...

9. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   ... total bilirubin =\< 3.0 x ULN with direct bilirubin =\< 1.5 x ULN in patients with well-documented Gilbert's syndrome) (obtained =\< 14 days prior to ...

10. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors - Mayo Clinic

    Total bilirubin ≤ institutional upper limit of normal (ULN) unless history of Gilbert's disease. Participants with history of Gilbert's disease must have ...